Related Experiment Video
Updated: May 2, 2026

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
2.8K
Gestational thyroid reference intervals in antibody-negative Chinese women
Feng-Xian Shen1, Zhen-Wei Xie1, Shi-Ming Lu1
1Women's Hospital, School of Medicine, Zhejiang University, Xueshi Road #2, Hangzhou 310006, China.
Clinical Biochemistry
|March 18, 2014
Summary
This study establishes gestation-specific reference intervals for thyroid function in pregnant Chinese women using the ARCHITECT analyzer. These new intervals differ from previous studies but align with similar analyzer findings.
Area of Science:
- Endocrinology
- Clinical Chemistry
- Reproductive Medicine
Background:
- Thyroid function changes significantly during pregnancy.
- Accurate interpretation requires gestation-specific reference intervals (GRIs).
- Previous GRIs may not be suitable for all populations or assay platforms.
Purpose of the Study:
- To establish GRIs for thyroid function assays in pregnant Chinese women.
- To compare these GRIs with those from other studies.
- To validate the use of the Abbott ARCHITECT analyzer for these measurements.
Main Methods:
- Thyroid antibody-negative pregnant Chinese women (N=1409) were enrolled.
- Thyroid function was assessed using the Abbott ARCHITECT i2000SR analyzer.
- Data were compared with 360 non-pregnant controls.
Main Results:
- Gestation-specific reference intervals (GRIs) were determined for TSH, FT4, and FT3 across trimesters.
- First trimester GRIs: TSH 0.16-3.78mIU/L, FT4 10.9-17.7pmol/L, FT3 2.9-5.0pmol/L.
- Second and third trimester GRIs showed trimester-specific ranges.
Conclusions:
- Established GRIs differ from prior Chinese studies using different analyzers.
- The findings are consistent with a Swiss study employing the same ARCHITECT analyzer.
- These new GRIs are valuable for interpreting thyroid function tests in pregnant women using the Abbott analyzer.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves' Disease I: Introduction
23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Goiter
32
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
32
Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
